Table 3.
Parameter | B | SE | 95% Wald confidence interval | Hypothesis test | |||
---|---|---|---|---|---|---|---|
Lower | Upper | Wald Chi-square | df | Sig | |||
(Intercept) | 1.89 | 0.582 | 0.75 | 3.03 | 10.55 | 1 | 0.001 |
SEX = M (F ref) | − 0.61 | 0.31 | − 1.22 | − 0.004 | 3.89 | 1 | 0.048 |
Antispastic drugs | − 1.44 | 0.54 | − 2.49 | − 0.38 | 7.17 | 1 | 0.007 |
Neurogenic bladder drugs | 1.98 | 0.51 | 0.99 | 2.98 | 15.21 | 1 | < 0.001 |
IPSS | 0.12 | 0.02 | 0.074 | 0.16 | 30.29 | 1 | < 0.001 |
Sphinteric FS EDSS | 1.61 | 0.22 | 1.19 | 2.03 | 55.78 | 1 | < 0.001 |
Ambulation EDSS | 0.30 | 0.082 | 0.14 | 0.46 | 13.30 | 1 | < 0.001 |
Likelihood ratio Chi-square: < 0.0001 |
NBDs Neurogenic bowel dysfunction score, SE standard error, M men, F female, IPSS International Prostatic Symptoms Score, FS functional system, EDSS Expanded Disability Status Scale